NCT05242172

Brief Summary

The CRP/albumin ratio (CAR) is a recently defined parameter which represents the ratio of a positive acute phase reactant to a negative acute phase reactant. Recent studies have shown that the CRP/albumin ratio is a biomarker with prognostic value for various inflammatory disorders and serious diseases. With this study it is aimed to investigate the effect of CRP/albumin ratio in predicting the severity and prognosis of the disease in pregnant patients with more severe Covid-19 infection.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
127

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 15, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 16, 2022

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2022

Completed
Last Updated

February 16, 2022

Status Verified

January 1, 2022

Enrollment Period

1 month

First QC Date

February 15, 2022

Last Update Submit

February 15, 2022

Conditions

Corona Virus InfectionPregnancy; Infection

Outcome Measures

Primary Outcomes (1)

  • CRP/Albumin ratio

    First day of hospital stay

Interventions

CRP/Albumin ratioDIAGNOSTIC_TEST

it is aimed to investigate prognosis and severity of covid-19 infection with using CRP/Albumin ratio in pregnant patient

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPregnant women
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

hospitalised Covid PCR test positive pregnant patient

You may qualify if:

  • Covid PCR test positive patients
  • Pregnant

You may not qualify if:

  • Covid PCR test negative
  • Missed data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Adıyaman Training and Research Hospital

Adıyaman, 02200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Coronavirus InfectionsPregnancy Complications, Infectious

Condition Hierarchy (Ancestors)

Coronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsVirus DiseasesInfectionsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 15, 2022

First Posted

February 16, 2022

Study Start

January 15, 2022

Primary Completion

February 15, 2022

Study Completion

February 28, 2022

Last Updated

February 16, 2022

Record last verified: 2022-01

Data Sharing

IPD Sharing
Will not share

Locations

TU(1)